By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment for the next stage of its CENDIFOX trial. The study will assess the safety and effects of ...
Over the past two decades, awareness has grown about the wide-ranging applications of genomic technologies in human health and beyond.1 This awareness was further heightened during the coronavirus ...
Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colon and appendiceal cancersBASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE ...
Tomaso Wilkins, a cancer survivor from Penn Valley, will run his first marathon in Sacramento this Sunday. A 24-year-old cancer survivor from Penn Valley will run his first marathon in Sacramento this ...
Furthermore, the growth in the number of diagnostics laboratories in developed countries is expected to drive the market growth in the next few years. Increase in incidences and prevalence of various ...